In two early trials, blood cancer treatment appears promising for deadly brain tumor

  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Kaitlin Sullivan is a contributor for NBCNews.com who has worked with NBC News Investigations. She reports on health, science and the environment and is a graduate of the Craig Newmark Graduate School of Journalism at City University of New York.

Two early trials published Wednesday showed promise in treating one of the deadliest types of cancer, glioblastoma. The aggressive brain cancer, which took the lives of John McCain and Beau Biden, is only diagnosed at stage 4, and the five-year survival rate is around 10%. The disease has no cure and, according to Dr.

To further prevent the CAR-T cells from escaping, the researchers bulked them up by binding them to an antibody, which made it more difficult for the cells to cross the blood-brain barrier and enter the bloodstream. All three patients — two who were in their 70s and one in her late 50s — responded quickly to the treatment. Brain scans showed their tumors shrunk significantly within a day of receiving the therapy.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 707. in HEALTH

Health Health Latest News, Health Health Headlines